DK1117383T3 - Doseringsformer omfattende terapeutisk formulering - Google Patents
Doseringsformer omfattende terapeutisk formuleringInfo
- Publication number
- DK1117383T3 DK1117383T3 DK99948122T DK99948122T DK1117383T3 DK 1117383 T3 DK1117383 T3 DK 1117383T3 DK 99948122 T DK99948122 T DK 99948122T DK 99948122 T DK99948122 T DK 99948122T DK 1117383 T3 DK1117383 T3 DK 1117383T3
- Authority
- DK
- Denmark
- Prior art keywords
- dosage forms
- therapeutic formulation
- dosage form
- drug formulation
- capsule
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9940198P | 1998-09-08 | 1998-09-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1117383T3 true DK1117383T3 (da) | 2006-04-03 |
Family
ID=22274837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99948122T DK1117383T3 (da) | 1998-09-08 | 1999-09-03 | Doseringsformer omfattende terapeutisk formulering |
Country Status (10)
Country | Link |
---|---|
US (5) | US6551613B1 (es) |
EP (1) | EP1117383B1 (es) |
JP (1) | JP2002524151A (es) |
AT (1) | ATE310508T1 (es) |
AU (1) | AU6136199A (es) |
CY (1) | CY1105388T1 (es) |
DE (1) | DE69928554T2 (es) |
DK (1) | DK1117383T3 (es) |
ES (1) | ES2249915T3 (es) |
WO (1) | WO2000013674A1 (es) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
JP2003516345A (ja) * | 1999-12-09 | 2003-05-13 | アルザ・コーポレーション | 抗ウイルス剤 |
MXPA02008261A (es) | 2000-02-24 | 2002-11-29 | Monsanto Technology Llc | Formulaciones inyectables no acuosas para liberacion prolongada de somatotorpina. |
KR20030023878A (ko) | 2000-06-26 | 2003-03-20 | 몬산토 테크놀로지 엘엘씨 | 소마토트로핀의 지속적인 방출을 위한 계면활성제 함유비수성 제제들 |
US6664234B1 (en) | 2000-06-30 | 2003-12-16 | Monsanto Technology Llc | Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin |
WO2003053401A2 (en) * | 2001-12-19 | 2003-07-03 | Alza Corporation | Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
AU2003245738A1 (en) * | 2002-06-28 | 2004-01-19 | Alza Corporation C/O Johnson & Johnson | Oral dosage from comprising a liquid active agent formulation andcontrolling release thereof by an expandable osmotic composition |
US20050232995A1 (en) * | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
WO2004041246A1 (en) * | 2002-10-31 | 2004-05-21 | Alza Corporation | Pharmaceutical formulation providing an increased biovailability of hydrophobic drugs |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
AU2004261277A1 (en) * | 2003-07-31 | 2005-02-10 | Alza Corporation | Permeation-Resistant osmotic engine and dosage form for controlled release of a liquid active agent formulation |
DE602004006763T2 (de) * | 2003-09-26 | 2008-02-07 | Alza Corp., Mountain View | Darreichungsform zur kontrollierten Freisetzung einer Formulierung mit aktivem Mittel und Verfahren zur Herstellung der Darreichungsform |
WO2005048981A1 (en) * | 2003-11-14 | 2005-06-02 | Alza Corporation | Controlled release of topirimate in liquid dosage forms |
AU2005265617B2 (en) * | 2004-07-30 | 2010-09-30 | Wakunaga Pharmaceutical Co., Ltd. | Composition for capsule film, capsule film, and capsule made with the same |
DE602006003639D1 (de) * | 2005-01-27 | 2008-12-24 | Alza Corp | Orale osmotische darreichungsform mit membran mit hoher flussdichte |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
EP1874269A2 (en) * | 2005-04-19 | 2008-01-09 | Alza Corporation | Combination of tramadol and substances that comprise gabapentin |
AR055099A1 (es) * | 2005-07-28 | 2007-08-08 | Alza Corp | Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol |
PL116330U1 (en) * | 2005-10-31 | 2007-04-02 | Alza Corp | Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation |
US20070196487A1 (en) * | 2006-02-16 | 2007-08-23 | Geerke Johan H | Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy |
MX2008014870A (es) | 2006-05-30 | 2009-02-12 | Intarcia Therapeutics Inc | Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas. |
DK2359808T3 (da) | 2006-08-09 | 2013-08-05 | Intarcia Therapeutics Inc | Osmotiske leveringssystemer og stempelaggregater |
US7538652B2 (en) * | 2006-08-29 | 2009-05-26 | International Business Machines Corporation | Electrical component tuned by conductive layer deletion |
EP2157967B1 (en) | 2007-04-23 | 2013-01-16 | Intarcia Therapeutics, Inc | Suspension formulations of insulinotropic peptides and uses thereof |
US8764702B2 (en) * | 2007-07-05 | 2014-07-01 | Baxter International Inc. | Dialysis system having dual patient line connection and prime |
WO2009102467A2 (en) | 2008-02-13 | 2009-08-20 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
EP2145643A1 (de) * | 2008-07-19 | 2010-01-20 | Markus Storz | Portioniertes Arzneimittel |
WO2011021594A1 (ja) | 2009-08-18 | 2011-02-24 | 国立大学法人東北大学 | 持続性ドラッグデリバリーシステム |
LT2462246T (lt) | 2009-09-28 | 2017-11-27 | Intarcia Therapeutics, Inc | Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas |
AU2010341516B2 (en) | 2009-12-21 | 2014-01-16 | Ambrx, Inc. | Modified bovine somatotropin polypeptides and their uses |
JP2013515081A (ja) | 2009-12-21 | 2013-05-02 | アンブルックス,インコーポレイテッド | 修飾されているブタのソマトトロピンポリペプチドおよびそれらの使用 |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
US9089529B2 (en) | 2011-10-25 | 2015-07-28 | Prothena Therapeutics Limited | Antibody formulations and methods |
US9199044B2 (en) | 2012-08-06 | 2015-12-01 | Elwha Llc | Devices and methods for wearable injection guides |
US9629963B2 (en) | 2012-10-30 | 2017-04-25 | Elwha Llc | Systems and methods for generating an injection guide |
US10046119B2 (en) | 2012-10-30 | 2018-08-14 | Elwha Llc | Systems and methods for generating an injection guide |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
US10925639B2 (en) | 2015-06-03 | 2021-02-23 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
EP3733694A1 (en) | 2016-05-16 | 2020-11-04 | Intarcia Therapeutics, Inc | Glucagon-receptor selective polypeptides and methods of use thereof |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
CN110225762A (zh) | 2017-01-03 | 2019-09-10 | 因塔西亚制药公司 | 包括glp-1受体激动剂的连续施用和药物的共同施用的方法 |
USD933219S1 (en) | 2018-07-13 | 2021-10-12 | Intarcia Therapeutics, Inc. | Implant removal tool and assembly |
CN111251521B (zh) * | 2018-12-03 | 2022-07-22 | 沈欣 | 液态珠丸的制造方法 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3173876A (en) | 1960-05-27 | 1965-03-16 | John C Zobrist | Cleaning methods and compositions |
NL271831A (es) | 1960-11-29 | |||
US3276586A (en) | 1963-08-30 | 1966-10-04 | Rosaen Filter Co | Indicating means for fluid filters |
US3546142A (en) | 1967-01-19 | 1970-12-08 | Amicon Corp | Polyelectrolyte structures |
US3541006A (en) | 1968-07-03 | 1970-11-17 | Amicon Corp | Ultrafiltration process |
US3541005A (en) | 1969-02-05 | 1970-11-17 | Amicon Corp | Continuous ultrafiltration of macromolecular solutions |
US3905360A (en) | 1971-11-01 | 1975-09-16 | Alza Corp | Intrauterine device for governing the reproductive process |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4077407A (en) | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
US4111201A (en) | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for delivering selected beneficial agents having varying degrees of solubility |
US4259323A (en) | 1980-03-24 | 1981-03-31 | Hoffmann-La Roche Inc. | Potassium chloride emulsion |
US4627850A (en) * | 1983-11-02 | 1986-12-09 | Alza Corporation | Osmotic capsule |
JPS60186385A (ja) | 1984-01-30 | 1985-09-21 | 不二輸送機工業株式会社 | ロボツトハンドの微少移動装置 |
US4772474A (en) * | 1985-08-09 | 1988-09-20 | Alza Corporation | Dispenser with internal arrangement of lamina means for dispensing beneficial agent |
US4729793A (en) * | 1985-08-09 | 1988-03-08 | Alza Corporation | Composition for manufacturing wall of dispensing device |
GB2155889B (en) * | 1984-03-21 | 1988-03-02 | Alza Corp | Dispenser-capsule |
US4743247A (en) * | 1984-08-13 | 1988-05-10 | Alza Corporation | Process for manufacturing dosage form |
US4717718A (en) * | 1985-08-09 | 1988-01-05 | Alza Corporation | Device for the controlled delivery of a beneficial agent |
US4842867A (en) * | 1986-05-09 | 1989-06-27 | Alza Corporation | Pulsed drug delivery of doxylamine |
US5938654A (en) * | 1987-06-25 | 1999-08-17 | Alza Corporation | Osmotic device for delayed delivery of agent |
US5236689A (en) * | 1987-06-25 | 1993-08-17 | Alza Corporation | Multi-unit delivery system |
US5391381A (en) * | 1987-06-25 | 1995-02-21 | Alza Corporation | Dispenser capable of delivering plurality of drug units |
US4853229A (en) * | 1987-10-26 | 1989-08-01 | Alza Corporation | Method for adminstering tiny pills |
US4855141A (en) * | 1988-03-25 | 1989-08-08 | Alza Corporation | Device comprising means for protecting and dispensing fluid sensitive medicament |
US6200600B1 (en) * | 1989-02-16 | 2001-03-13 | Btg International Limited | Controlled delay release device |
US4951494A (en) | 1989-10-10 | 1990-08-28 | Alterio Joseph C D | Compression rollers with movable shoulder shields |
US5213809A (en) * | 1990-01-24 | 1993-05-25 | Alza Corporation | Delivery system comprising means for controlling internal pressure |
US5324280A (en) * | 1990-04-02 | 1994-06-28 | Alza Corporation | Osmotic dosage system for delivering a formulation comprising liquid carrier and drug |
US5443459A (en) * | 1991-01-30 | 1995-08-22 | Alza Corporation | Osmotic device for delayed delivery of agent |
US5223265A (en) * | 1992-01-10 | 1993-06-29 | Alza Corporation | Osmotic device with delayed activation of drug delivery |
US5209746A (en) * | 1992-02-18 | 1993-05-11 | Alza Corporation | Osmotically driven delivery devices with pulsatile effect |
US5869097A (en) * | 1992-11-02 | 1999-02-09 | Alza Corporation | Method of therapy comprising an osmotic caplet |
US5358721A (en) * | 1992-12-04 | 1994-10-25 | Alza Corporation | Antiviral therapy |
DE69425453T2 (de) * | 1993-04-23 | 2001-04-12 | Novartis Ag, Basel | Wirkstoffabgabevorrichtung mit gesteuerter Freigabe |
US5446090A (en) * | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
US5633011A (en) | 1994-08-04 | 1997-05-27 | Alza Corporation | Progesterone replacement therapy |
US5614578A (en) * | 1994-10-28 | 1997-03-25 | Alza Corporation | Injection-molded dosage form |
US5965160A (en) * | 1995-04-24 | 1999-10-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Self-emulsifiable formulation producing an oil-in-water emulsion |
IL128632A (en) * | 1996-08-22 | 2003-03-12 | Rtp Pharma Corp | Compositions comprising microparticles of water-insoluble substances and method for preparing same |
FR2765608B1 (fr) * | 1997-07-04 | 1999-09-10 | Manuf Stephanoise De Transform | Dispositif connecteur d'arceaux de tente |
US6087353A (en) * | 1998-05-15 | 2000-07-11 | Forbes Medi-Tech Inc. | Phytosterol compositions and use thereof in foods, beverages, pharmaceuticals, nutraceuticals and the like |
US6445783B1 (en) * | 1998-07-14 | 2002-09-03 | At&T Corp. | System and method that provides specialized processing of communications based on automatically generated identifiers |
US6183466B1 (en) * | 1998-08-21 | 2001-02-06 | Alza Corporation | Dosage form comprising a capsule |
WO2005031544A2 (en) * | 2003-09-26 | 2005-04-07 | Disney Enterprises, Inc. | Cell phone parental control |
US20060293057A1 (en) * | 2005-06-24 | 2006-12-28 | Mazerski Thomas M | System and method for secure web-based mobile phone parental controls |
US20080046930A1 (en) * | 2006-08-17 | 2008-02-21 | Bellsouth Intellectual Property Corporation | Apparatus, Methods and Computer Program Products for Audience-Adaptive Control of Content Presentation |
US7996005B2 (en) * | 2007-01-17 | 2011-08-09 | Eagency, Inc. | Mobile communication device monitoring systems and methods |
EP2044943A1 (en) * | 2007-10-04 | 2009-04-08 | Solvay Pharmaceuticals, Inc. | Pharmaceutical compositions comprising esterified estrogens and methyltestosterone and method of using the same |
-
1999
- 1999-07-14 US US09/353,519 patent/US6551613B1/en not_active Expired - Fee Related
- 1999-09-03 DE DE69928554T patent/DE69928554T2/de not_active Expired - Lifetime
- 1999-09-03 EP EP99948122A patent/EP1117383B1/en not_active Expired - Lifetime
- 1999-09-03 WO PCT/US1999/020333 patent/WO2000013674A1/en active IP Right Grant
- 1999-09-03 AU AU61361/99A patent/AU6136199A/en not_active Abandoned
- 1999-09-03 JP JP2000568483A patent/JP2002524151A/ja active Pending
- 1999-09-03 DK DK99948122T patent/DK1117383T3/da active
- 1999-09-03 AT AT99948122T patent/ATE310508T1/de not_active IP Right Cessation
- 1999-09-03 ES ES99948122T patent/ES2249915T3/es not_active Expired - Lifetime
-
2003
- 2003-02-24 US US10/373,529 patent/US20030157163A1/en not_active Abandoned
-
2006
- 2006-01-16 CY CY20061100047T patent/CY1105388T1/el unknown
-
2008
- 2008-04-02 US US12/060,885 patent/US20080181944A1/en not_active Abandoned
-
2009
- 2009-01-23 US US12/359,235 patent/US20090130204A1/en not_active Abandoned
-
2010
- 2010-03-02 US US12/716,185 patent/US20100159002A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000013674A1 (en) | 2000-03-16 |
DE69928554T2 (de) | 2006-03-30 |
AU6136199A (en) | 2000-03-27 |
EP1117383A1 (en) | 2001-07-25 |
EP1117383B1 (en) | 2005-11-23 |
DE69928554D1 (de) | 2005-12-29 |
CY1105388T1 (el) | 2010-04-28 |
US20030157163A1 (en) | 2003-08-21 |
US20080181944A1 (en) | 2008-07-31 |
JP2002524151A (ja) | 2002-08-06 |
US20100159002A1 (en) | 2010-06-24 |
US20090130204A1 (en) | 2009-05-21 |
ES2249915T3 (es) | 2006-04-01 |
US6551613B1 (en) | 2003-04-22 |
ATE310508T1 (de) | 2005-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1117383T3 (da) | Doseringsformer omfattende terapeutisk formulering | |
HK1031197A1 (en) | Osmotic dosage form comprising first and second coats | |
CY1107512T1 (el) | Νεες υποκατεστημενες με βενζιμιδαζολιο μορφες δοσολογιας και μεθοδος για τη χρηση τους | |
NO971206D0 (no) | Forlenget-frigjöringsformulering | |
CY1112260T1 (el) | Σκευασματα υδροκωδονης ελεγχομενης απελευθερωσης | |
HUP0004383A2 (hu) | Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény | |
BR0015188A (pt) | Composições farmacêuticas | |
DE69620606D1 (de) | Feste oral anzuwendende arzeneiform | |
IL80149A (en) | Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases | |
DE59802670D1 (de) | Osmotisches arzneimittelfreisetzungssystem | |
ES2099275T3 (es) | Comprimido multiparticulas de desleimiento rapido. | |
IS4146A (is) | Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara | |
ATE424810T1 (de) | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung | |
ATE198152T1 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
ATE252377T1 (de) | Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff | |
NZ514129A (en) | Tolperison-containing, pharmaceutical preparation for oral administration | |
DK1007006T3 (da) | Formulering af cefadroxilmonohydrattablet | |
EA199900102A1 (ru) | Таблетка малеата тримебутина, покрытая оболочкой | |
GR20010100377A (el) | Φαρμακευτικη συνθεση περιεχουσα σιταλοπραμη | |
MXPA04003506A (es) | Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn. | |
NZ331083A (en) | Pharmaceutical preparations of cilansetron stabilized against racemization | |
NO975634L (no) | Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater | |
BG94934A (bg) | Твърди лекарствени форми за орално приложение,съдържащи ифосфамид като активно вещество | |
CA2409845A1 (en) | Active substance combination containing a compound with an opioid effect and at least one further compound of formula i | |
CA2099585A1 (en) | Pharmaceutical compositions |